{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:43:45Z","timestamp":1793785425266,"version":"4.6.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.neo.2023.100947","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:43:53Z","timestamp":1698738233000},"page":"100947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Acral melanoma: new insights into the immune and genomic landscape"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5720-5910","authenticated-orcid":false,"given":"Larissa Anastacio DaCosta","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7149-6531","authenticated-orcid":false,"given":"Flavia C.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1089-9307","authenticated-orcid":false,"given":"Keiran S.M.","family":"Smalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2899-0969","authenticated-orcid":false,"given":"Patricia A.","family":"Possik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2023.100947_bib0001","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","article-title":"Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005","volume":"145","author":"Bradford","year":"2009","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.neo.2023.100947_bib0002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00000478-197706000-00004","article-title":"Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma","volume":"1","author":"Arrington","year":"1977","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.neo.2023.100947_bib0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2019.10.017","article-title":"Translational pathology, genomics and the development of systemic therapies for acral melanoma","volume":"61","author":"Chen","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.neo.2023.100947_bib0004","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/pcmr.12279","article-title":"The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis","volume":"27","author":"Furney","year":"2014","journal-title":"Pigment. Cell Melanoma Res."},{"key":"10.1016\/j.neo.2023.100947_bib0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neo.2023.100947_bib0006","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0007","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0008","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/jnci\/djz005","article-title":"Targeted genomic profiling of acral melanoma","volume":"111","author":"Yeh","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.neo.2023.100947_bib0009","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1038\/s41467-020-18988-3","article-title":"Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity","volume":"11","author":"Newell","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2023.100947_bib0010","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1158\/2159-8290.CD-22-0603","article-title":"Comparative genomics provides etiologic and biological insight into melanoma subtypes","volume":"12","author":"Newell","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2023.100947_bib0011","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1158\/1078-0432.CCR-21-3145","article-title":"Single-cell characterization of the cellular landscape of acral melanoma identifies novel targets for immunotherapy","volume":"28","author":"Li","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2023.100947_bib0012","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78616","article-title":"Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments","volume":"11","author":"He","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.neo.2023.100947_bib0013","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1038\/s41467-022-34877-3","article-title":"A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2023.100947_bib0014","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamadermatol.2013.5853","article-title":"A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress","volume":"149","author":"Jung","year":"2013","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.neo.2023.100947_bib0015","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1056\/NEJMc1512354","article-title":"Melanomas and mechanical stress points on the plantar surface of the foot","volume":"374","author":"Minagawa","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0016","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1038\/s41598-017-05809-9","article-title":"A clinicopathological analysis of 153 acral melanomas and the relevance of mechanical stress","volume":"7","author":"Sheen","year":"2017","journal-title":"Sci. rep."},{"key":"10.1016\/j.neo.2023.100947_bib0017","doi-asserted-by":"crossref","first-page":"31432","DOI":"10.1038\/srep31432","article-title":"Acral melanoma in Chinese: a clinicopathological and prognostic study of 142 cases","volume":"6","author":"Lv","year":"2016","journal-title":"Sci. rep."},{"key":"10.1016\/j.neo.2023.100947_bib0018","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMc1706162","article-title":"Acral melanoma and mechanical stress on the plantar surface of the foot","volume":"377","author":"Costello","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0019","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0025-6196(11)61033-1","article-title":"Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis","volume":"82","author":"Markovic","year":"2007","journal-title":"Mayo. Clin. Proc."},{"key":"10.1016\/j.neo.2023.100947_bib0020","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.5888\/pcd16.180640","article-title":"Melanoma among non-hispanic black Americans","volume":"16","author":"Culp","year":"2019","journal-title":"Prev. Chronic. Dis."},{"key":"10.1016\/j.neo.2023.100947_bib0021","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/pcmr.12885","article-title":"Acral lentiginous melanoma: basic facts, biological characteristics and research perspectives of an understudied disease","volume":"34","author":"Basurto-Lozada","year":"2021","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.neo.2023.100947_bib0022","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.arcmed.2022.11.008","article-title":"Immunotherapy options for acral melanoma, a fast-growing but neglected malignancy","volume":"53","author":"Gajon","year":"2022","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.neo.2023.100947_bib0023","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1245\/s10434-016-5394-x","article-title":"Melanoma in Mexico: clinicopathologic features in a population with predominance of acral lentiginous subtype","volume":"23","author":"Lino-Silva","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0024","doi-asserted-by":"crossref","first-page":"246","DOI":"10.7196\/SAMJ.2019.v109i4.13565","article-title":"The incidence of melanoma in South Africa: An exploratory analysis of national cancer registry data from 2005 to 2013 with a specific focus on melanoma in black Africans","volume":"109","author":"Tod","year":"2019","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.neo.2023.100947_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41568-022-00443-8","article-title":"Un-fair skin: racial disparities in acral melanoma research","volume":"22","author":"Alicea","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2023.100947_bib0026","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bjd.21274","article-title":"Does the morphology of cutaneous melanoma help to explain the international differences in survival? results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3)","volume":"187","author":"Di Carlo","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.neo.2023.100947_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined Dabrafenib and Trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0029","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.neo.2023.100947_bib0030","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat. genet."},{"key":"10.1016\/j.neo.2023.100947_bib0031","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1101\/gr.213348.116","article-title":"Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma","volume":"27","author":"Liang","year":"2017","journal-title":"Genome. Res."},{"key":"10.1016\/j.neo.2023.100947_bib0032","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2020.08.006","article-title":"Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs","volume":"183","author":"Hadi","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.neo.2023.100947_bib0033","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41467-022-29925-x","article-title":"Weight-bearing activity impairs nuclear membrane and genome integrity via YAP activation in plantar melanoma","volume":"13","author":"Seo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2023.100947_bib0034","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/pcmr.13034","article-title":"Systematic review and meta-analysis of genomic alterations in acral melanoma","volume":"35","author":"Broit","year":"2022","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.neo.2023.100947_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neo.2023.100947_bib0036","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-21-3344","article-title":"Integrative genomic profiling uncovers therapeutic targets of acral melanoma in Asian populations","volume":"28","author":"Shi","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2023.100947_bib0037","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/1346-8138.16579","article-title":"Genomic profiling with whole-exome sequencing revealed distinct mutations and novel pathways in Asian melanoma","volume":"49","author":"Chiu","year":"2022","journal-title":"J. Dermatol."},{"key":"10.1016\/j.neo.2023.100947_bib0038","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13073-022-01068-0","article-title":"Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes","volume":"14","author":"Wang","year":"2022","journal-title":"Genome. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0039","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41467-022-28566-4","article-title":"Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis","volume":"13","author":"Farshidfar","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2023.100947_bib0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41586-022-04584-6","article-title":"Anatomic position determines oncogenic specificity in melanoma","volume":"604","author":"Weiss","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neo.2023.100947_bib0041","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamadermatol.2021.0793","article-title":"A mutational survey of acral Nevi","volume":"157","author":"Smalley","year":"2021","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.neo.2023.100947_bib0042","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neo.2023.100947_bib0043","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","article-title":"Toward minimal residual disease-directed therapy in melanoma","volume":"174","author":"Rambow","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neo.2023.100947_bib0044","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1158\/1078-0432.CCR-21-1694","article-title":"Single-cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases","volume":"27","author":"Smalley","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2023.100947_bib0045","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1038\/s41467-021-24767-5","article-title":"A human CD137xPD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade","volume":"12","author":"Geuijen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2023.100947_bib80","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007567","article-title":"Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma","volume":"11","author":"Augustin","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.neo.2023.100947_bib0046","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa2109970","article-title":"Relatlimab and Nivolumab versus Nivolumab in untreated advanced melanoma","volume":"386","author":"Tawbi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0047","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1158\/1078-0432.CCR-19-3922","article-title":"Safety, efficacy, and biomarker analysis of Toripalimab in previously treated advanced melanoma: results of the POLARIS-01 multicenter phase II trial","volume":"26","author":"Tang","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2023.100947_bib0048","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000341","article-title":"Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma","volume":"8","author":"Klemen","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.neo.2023.100947_bib0049","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.19.01464","article-title":"Long-term outcomes and responses to retreatment in patients with melanoma treated with PD-1 blockade","volume":"38","author":"Betof Warner","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2018.09.025","article-title":"Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study","volume":"105","author":"Namikawa","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neo.2023.100947_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.882471","article-title":"Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study","volume":"13","author":"Si","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2023.100947_bib0052","article-title":"Positive association between location of melanoma, ultraviolet signature, tumor mutational burden, and response to anti-PD-1 therapy","volume":"5","author":"Dousset","year":"2021","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0053","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004879","article-title":"Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study","volume":"10","author":"Shui","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.neo.2023.100947_bib0054","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","article-title":"Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0055","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.annonc.2020.05.031","article-title":"Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients","volume":"31","author":"Nakamura","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0056","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004668","article-title":"Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma","volume":"10","author":"Bhave","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.neo.2023.100947_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.524700","article-title":"Poor lymphocyte infiltration to primary tumors in acral lentiginous melanoma and mucosal melanoma compared to cutaneous melanoma","volume":"10","author":"Nakamura","year":"2020","journal-title":"front. oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0058","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall Survival benefit with Tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0059","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231160140","article-title":"Tebentafusp: a first-in-class treatment for metastatic uveal melanoma","volume":"15","author":"Howlett","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41586-022-05368-8","article-title":"Neoadjuvant relatlimab and nivolumab in resectable melanoma","volume":"611","author":"Amaria","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neo.2023.100947_bib0061","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJMoa2035716","article-title":"Lenvatinib plus Pembrolizumab or Everolimus for advanced renal cell carcinoma","volume":"384","author":"Motzer","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0062","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1470-2045(19)30020-8","article-title":"Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial","volume":"20","author":"Makker","year":"2019","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0063","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157347","article-title":"Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanoma","volume":"8","author":"Tran","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.neo.2023.100947_bib0064","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4149\/neo_2017_419","article-title":"BRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and mucosal melanoma","volume":"64","author":"Bai","year":"2017","journal-title":"Neoplasma"},{"key":"10.1016\/j.neo.2023.100947_bib0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tranon.2016.09.004","article-title":"Efficacy of BRAF Inhibitors in Asian metastatic melanoma patients: potential implications of genomic sequencing in BRAF-mutated melanoma","volume":"9","author":"Kim","year":"2016","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0066","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.bjc.6604482","article-title":"Phase II trial of Imatinib Mesylate in patients with metastatic melanoma","volume":"99","author":"Kim","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neo.2023.100947_bib0067","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/sj.bjc.6602529","article-title":"Lack of clinical efficacy of imatinib in metastatic melanoma","volume":"92","author":"Ugurel","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neo.2023.100947_bib0068","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2007.14.0707","article-title":"Major response to Imatinib Mesylate in KIT-mutated melanoma","volume":"26","author":"Hodi","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0069","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejca.2021.08.015","article-title":"c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis","volume":"157","author":"Steeb","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neo.2023.100947_bib0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejca.2021.02.021","article-title":"Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway","volume":"148","author":"Mao","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neo.2023.100947_bib0071","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jaad.2020.08.097","article-title":"The ongoing racial disparities in melanoma: an analysis of the surveillance, epidemiology, and end results database (1975-2016)","volume":"84","author":"Qian","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.neo.2023.100947_bib0072","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/archinte.166.17.1907","article-title":"Ethnic differences among patients with cutaneous melanoma","volume":"166","author":"Cormier","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neo.2023.100947_bib0073","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1200\/JCO.2007.12.3604","article-title":"Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment","volume":"26","author":"Zell","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2023.100947_bib0074","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jss.2020.02.010","article-title":"Acral lentiginous melanoma: incidence and survival in the United States, 2006-2015, an analysis of the SEER registry","volume":"251","author":"Huang","year":"2020","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.neo.2023.100947_bib0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bjd.21241","article-title":"Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study","volume":"187","author":"Bai","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.neo.2023.100947_bib0076","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/CMR.0000000000000476","article-title":"Acral melanoma: a retrospective cohort from the Brazilian national cancer institute (INCA)","volume":"28","author":"Nunes","year":"2018","journal-title":"Melanoma Res."},{"key":"10.1016\/j.neo.2023.100947_bib0077","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/bjd.19406","article-title":"Racial and ethnic differences in the clinical presentation and outcomes of acral lentiginous melanoma","volume":"184","author":"Behbahani","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.neo.2023.100947_bib0078","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/CJI.0000000000000264","article-title":"Racial and socioeconomic disparities in the delivery of immunotherapy for metastatic melanoma in the United States","volume":"42","author":"Haque","year":"2019","journal-title":"J. Immunother."},{"key":"10.1016\/j.neo.2023.100947_bib0079","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2018.09.013","article-title":"Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries","volume":"104","author":"Kandolf Sekulovic","year":"2018","journal-title":"Eur. J. Cancer"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558623000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558623000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:13:57Z","timestamp":1761484437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558623000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":80,"alternative-id":["S1476558623000714"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2023.100947","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acral melanoma: new insights into the immune and genomic landscape","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2023.100947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100947"}}